In this issue:
Is the collection of hematopoietic progenitor cells for possible salvage ASCT worthwhile?
AlloSCT for patients with lower-risk myelodysplastic syndrome
The TERS predicts survival after alloSCT
Transjugular intrahepatic portosystemic shunt for very severe VOD/SOS
ASCT with reduced-intensity conditioning regimens in refractory Takayasu arteritis
Haploidentical and HLA-matched transplant recipients benefit from combination GvHD prophylaxis
Extramedullary relapse after alloSCT in patients with adult ALL
Anti-PD-1 monoclonal antibodies before and after alloSCT for relapsed or refractory Hodgkin lymphoma
Please login below to download this issue (PDF)